Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
2019 · Nature Communications · 149 citations
https://doi.org/10.1038/s41467-019-12472-3
A
Antonia Follenzi
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
223
Papers
11.4K
Citations
55
h-index
119
i10-index
Antonia Follenzi is an academic researcher from Università degli Studi del Piemonte Orientale “Amedeo Avogadro”. The author has contributed to research in topics: Hemophilia Treatment and Research & Virus-based gene therapy research & RNA Interference and Gene Delivery. The author has an h-index of 55, co-authored 190 publications.
ORCID: 0000-0001-9780-300XPapers by this author
worksBiological and clinical implications of <i>BIRC3</i> mutations in chronic lymphocytic leukemia
2019 · Haematologica · 82 citations
https://doi.org/10.3324/haematol.2019.219550
Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates
2022 · Nature Communications · 44 citations
https://doi.org/10.1038/s41467-022-30102-3
Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes
2023 · Nature Communications · 34 citations
https://doi.org/10.1038/s41467-023-36582-1
Lymphoblastoid cell lines from Diamond Blackfan anaemia patients exhibit a full ribosomal stress phenotype that is rescued by gene therapy
2017 · Scientific Reports · 26 citations
https://doi.org/10.1038/s41598-017-12307-5
Therapeutic correction of hemophilia A by transplantation of hPSC-derived liver sinusoidal endothelial cell progenitors
2022 · Cell Reports · 22 citations
https://doi.org/10.1016/j.celrep.2022.110621
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat